ATROVENT Inhaler CFC-Free 20 mcg/actuation pressurised inhalation solution Malta - English - Medicines Authority

atrovent inhaler cfc-free 20 mcg/actuation pressurised inhalation solution

boehringer ingelheim limited - ipratropium bromide - pressurised inhalation, solution - ipratropium bromide 20 µg - drugs for obstructive airway diseases

Atrovent 20micrograms/dose inhaler CFC free United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

atrovent 20micrograms/dose inhaler cfc free

boehringer ingelheim ltd - ipratropium bromide - pressurised inhalation - 20microgram/1dose

PTFE Polymer Oval Pledgets - Cardiovascular patch, synthetic Australia - English - Department of Health (Therapeutic Goods Administration)

ptfe polymer oval pledgets - cardiovascular patch, synthetic

medtronic australasia pty ltd - 31744 - cardiovascular patch, synthetic - ptfe polymer oval pledgets are nonabsorbable, undyed fabrics composed of poly (tetrafluoroethylene). ptfe pledgets elicit a minimal acute inflammatory reaction in tissues, followed by gradual encapsulation of the fabric by fibrous connective tissue. ptfe pledgets are not absorbed, nor is any significant change in tensile strength retention known to occur in vivo. ptfe polymer oval pledgets are indicated for use as non-absorbable suture buttresses when there is a possibility of suture tearing through tissue. these pledgets are used in various surgical procedures such as vascular closure, septal repair, myocardial closure, valvular suturing and hepatic repair.

Glytrin 400 micrograms per metered dose Sublingual Spray Ireland - English - HPRA (Health Products Regulatory Authority)

glytrin 400 micrograms per metered dose sublingual spray

ayrton saunders (ireland) limited - glyceryl trinitrate - sublingual spray, solution - 0.7%w/w percent weight/weight - organic nitrates; glyceryl trinitrate

XOFIGO Israel - English - Ministry of Health

xofigo

bayer israel ltd - radium-223 dichloride - solution for injection - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride - xofigo monotherapy or in combination with luteinising hormone releasing hormone (lhrh) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced pc (other than lhrh analogues), or ineligible for any available systemic mcrpc treatment.

XOFIGO Israel - English - Ministry of Health

xofigo

bayer israel ltd - radium-223 dichloride - solution for injection - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride - xofigo monotherapy or in combination with luteinising hormone releasing hormone (lhrh) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced pc (other than lhrh analogues), or ineligible for any available systemic mcrpc treatment.